Mortality trends of amyotrophic lateral sclerosis in Norway 1951–2014: an age–period–cohort study

Journal of Neurology

Volumn 263, Issue 12, 2016, Pages 2378-2385

  Nakken, Ola ^a,b   Lindstrøm, Jonas Christoffer ^a,b   Tysnes, Ole Bjørn ^c,d   Holmøy, Trygve ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF BERGEN   (Norway)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Age period cohort model; ALS; MND; Mortality; Neuro epidemiology; Neurodegenerative disorders

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BIRTH RATE; COHORT ANALYSIS; ENVIRONMENTAL EXPOSURE; FEMALE; GROUPS BY AGE; HUMAN; LIFESTYLE; MALE; MORTALITY RATE; NORWAY; PRIORITY JOURNAL; RISK FACTOR; SEX RATIO; AGE; INCIDENCE; MORTALITY; REGRESSION ANALYSIS; SEX DIFFERENCE;

AGE DISTRIBUTION; AGE FACTORS; AMYOTROPHIC LATERAL SCLEROSIS; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; MALE; NORWAY; REGRESSION ANALYSIS; SEX FACTORS;

EID: 84984846869     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-016-8273-2     Document Type: Article

References (30)

1. Al-Chalabi A, Hardiman O (2013) The epidemiology of ALS: a conspiracy of genes, environment and time. Nat Rev Neurol 9(11):617–628. doi:10.1038/nrneurol.2013.203
2. Ingre C, Roos PM, Piehl F, Kamel F, Fang F (2015) Risk factors for amyotrophic lateral sclerosis. Clin Epidemiol 7:181–193. doi:10.2147/clep.s37505
3. Marin B, Couratier P, Preux PM, Logroscino G (2011) Can mortality data be used to estimate amyotrophic lateral sclerosis incidence? Neuroepidemiology 36(1):29–38. doi:10.1159/000321930
4. Holford TR (1991) Understanding the effects of age, period, and cohort on incidence and mortality rates. Annu Rev Public Health 12:425–457. doi:10.1146/annurev.pu.12.050191.002233
5. Seals RM, Hansen J, Gredal O, Weisskopf MG (2013) Age–period–cohort analysis of trends in amyotrophic lateral sclerosis in Denmark, 1970–2009. Am J Epidemiol 178(8):1265–1271. doi:10.1093/aje/kwt116
6. Gordon PH, Artaud F, Aouba A, Laurent F, Meininger V, Elbaz A (2011) Changing mortality for motor neuron disease in France (1968–2007): an age–period–cohort analysis. Eur J Epidemiol 26(9):729–737. doi:10.1007/s10654-011-9595-0
7. Ajdacic-Gross V, Schmid M, Tschopp A, Gutzwiller F (2012) Birth cohort effects in neurological diseases: amyotrophic lateral sclerosis. Parkinson’s disease and multiple sclerosis. Neuroepidemiology 38(1):56–63. doi:10.1159/000334632
8. Ajdacic-Gross V, Wang J, Gutzwiller F (1998) Season of birth in amyotrophic lateral sclerosis. Eur J Epidemiol 14(4):359–361
9. Willer CJ, Dyment DA, Sadovnick AD, Rothwell PM, Murray TJ, Ebers GC (2005) Timing of birth and risk of multiple sclerosis: population based study. BMJ (Clinical research ed) 330(7483):120. doi:10.1136/bmj.38301.686030.63
10. Grytten N, Torkildsen O, Aarseth JH, Benjaminsen E, Celius EG, Dahl OP, Holmoy T, Loken-Amsrud K, Midgard R, Myhr KM, Risberg G, Vatne A, Kampman MT (2013) Month of birth as a latitude-dependent risk factor for multiple sclerosis in Norway. Mult Scler (Houndmills, Basingstoke, England) 19(8):1028–1034. doi:10.1177/1352458512471094
11. Torrey EF, Miller J, Rawlings R, Yolken RH (2000) Seasonal birth patterns of neurological disorders. Neuroepidemiology 19(4):177–185. doi:10.1159/000026253
12. Fang F, Valdimarsdottir U, Bellocco R, Ronnevi LO, Sparen P, Fall K, Ye W (2009) Amyotrophic lateral sclerosis in Sweden, 1991–2005. Arch Neurol 66(4):515–519. doi:10.1001/archneurol.2009.13
13. Seljeseth YM, Vollset SE, Tysnes OB (2000) Increasing mortality from amyotrophic lateral sclerosis in Norway? Neurology 55(9):1262–1266
14. Carstensen B (2007) Age–period–cohort models for the Lexis diagram. Stat Med 26(15):3018–3045. doi:10.1002/sim.2764
15. Noonan CW, White MC, Thurman D, Wong LY (2005) Temporal and geographic variation in United States motor neuron disease mortality, 1969–1998. Neurology 64(7):1215–1221. doi:10.1212/01.wnl.0000156518.22559.7f
16. Lilienfeld DE, Chan E, Ehland J, Godbold J, Landrigan PJ, Marsh G, Perl DP (1989) Rising mortality from motoneuron disease in the USA, 1962–84. Lancet 1(8640):710–713
17. Valenzuela D, Zitko P, Lillo P (2015) Amyotrophic lateral sclerosis mortality rates in Chile: a population based study (1994–2010). Amyotroph Lateral Scler Frontotemp Degener. doi:10.3109/21678421.2015.1026827
18. Doi Y, Yokoyama T, Tango T, Takahashi K, Fujimoto K, Nakano I (2010) Temporal trends and geographic clusters of mortality from amyotrophic lateral sclerosis in Japan, 1995–2004. J Neurol Sci 298(1–2):78–84. doi:10.1016/j.jns.2010.08.004
19. Maasilta P, Jokelainen M, Loytonen M, Sabel CE, Gatrell AC (2001) Mortality from amyotrophic lateral sclerosis in Finland, 1986–1995. Acta Neurol Scand 104(4):232–235
20. Bostrom I, Riise T, Landtblom AM (2012) Mortality statistics for multiple sclerosis and amyotrophic lateral sclerosis in Sweden. Neuroepidemiology 38(4):245–249. doi:10.1159/000338031
21. Alonso A, Logroscino G, Jick SS, Hernan MA (2009) Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population-based study. Euro J Neurol 16(6):745–751
22. Byrne S, Jordan I, Elamin M, Hardiman O (2013) Age at onset of amyotrophic lateral sclerosis is proportional to life expectancy. Amyotroph Lateral Scler Frontotemp Degener 14(7–8):604–607. doi:10.3109/21678421.2013.809122
23. Neilson S, Gunnarsson LG, Robinson I (1994) Rising mortality from motor neurone disease in Sweden 1961–1990: the relative role of increased population life expectancy and environmental factors. Acta Neurol Scand 90(3):150–159
24. Neilson S, Robinson I, Nymoen EH (1994) Longitudinal analysis of amyotrophic lateral sclerosis mortality in Norway, 1966–1989: evidence for a susceptible subpopulation. J Neurol Sci 122(2):148–154
25. Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, Burrell JR, Zoing MC (2011) Amyotrophic lateral sclerosis. Lancet 377(9769):942–955. doi:10.1016/s0140-6736(10)61156-7
26. Beghi E, Logroscino G, Chio A, Hardiman O, Mitchell D, Swingler R, Traynor BJ (2006) The epidemiology of ALS and the role of population-based registries. Biochim Biophys Acta 1762(11–12):1150–1157. doi:10.1016/j.bbadis.2006.09.008
27. Brooks BR, Miller RG, Swash M, Munsat TL (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1(5):293–299
28. Tysnes OB, Vollset SE, Aarli JA (1991) Epidemiology of amyotrophic lateral sclerosis in Hordaland county, western Norway. Acta Neurol Scand 83(5):280–285
29. Fiddes B, Wason J, Kemppinen A, Ban M, Compston A, Sawcer S (2013) Confounding underlies the apparent month of birth effect in multiple sclerosis. Ann Neurol 73(6):714–720. doi:10.1002/ana.23925
30. Fiddes B, Wason J, Sawcer S (2014) Confounding in association studies: month of birth and multiple sclerosis. J Neurol 261(10):1851–1856. doi:10.1007/s00415-014-7241-y